IMNM saw its Momentum Indicator move below the 0 level on September 22, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator turned negative. In of the 50 cases, the stock moved further down in the following days. The odds of a decline are at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 29 cases where IMNM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMNM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IMNM broke above its upper Bollinger Band on September 11, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IMNM entered a downward trend on September 05, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IMNM's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IMNM just turned positive on September 08, 2023. Looking at past instances where IMNM's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .
IMNM moved above its 50-day moving average on September 21, 2023 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IMNM crossed bullishly above the 50-day moving average on September 19, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMNM advanced for three days, in of 150 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IMNM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.434) is normal, around the industry mean (22.634). P/E Ratio (0.000) is within average values for comparable stocks, (131.508). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.085). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (13.245) is also within normal values, averaging (305.056).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IMNM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Biotechnology
A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To IMNM | 1D Price Change % | ||
---|---|---|---|---|
IMNM | 100% | +0.21% | ||
MDGL - IMNM | 33% Loosely correlated | -3.87% | ||
BIOR - IMNM | 33% Poorly correlated | -2.74% | ||
JSPR - IMNM | 31% Poorly correlated | +3.83% | ||
ELOX - IMNM | 30% Poorly correlated | +3.29% | ||
AXLA - IMNM | 30% Poorly correlated | +7.81% | ||
More |